-
1
-
-
0035134761
-
Epidemiology and natural history of atrial fibrillation: Clinical implications
-
Chugh SS, Blackshear JL, Shen WK, Hammill SC, Gersh BJ. Epidemiology and natural history of atrial fibrillation: Clinical implications. J Am Coll Cardiol 2001;37: 371-378.
-
(2001)
J Am Coll Cardiol
, vol.37
, pp. 371-378
-
-
Chugh, S.S.1
Blackshear, J.L.2
Shen, W.K.3
Hammill, S.C.4
Gersh, B.J.5
-
2
-
-
77957699729
-
Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC
-
Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al- Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31: 2369-2429.
-
(2010)
Eur Heart J
, vol.31
, pp. 2369-2429
-
-
Camm, A.J.1
Kirchhof, P.2
Lip, G.Y.3
Schotten, U.4
Savelieva, I.5
Ernst, S.6
Van Gelder, I.C.7
Al-Attar, N.8
Hindricks, G.9
Prendergast, B.10
Heidbuchel, H.11
Alfieri, O.12
Angelini, A.13
Atar, D.14
Colonna, P.15
De Caterina, R.16
De Sutter, J.17
Goette, A.18
Gorenek, B.19
Heldal, M.20
Hohloser, S.H.21
Kolh, P.22
Le Heuzey, J.Y.23
Ponikowski, P.24
Rutten, F.H.25
more..
-
3
-
-
84868523625
-
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association
-
Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33: 2719-2747.
-
(2012)
Eur Heart J
, vol.33
, pp. 2719-2747
-
-
Camm, A.J.1
Lip, G.Y.2
De Caterina, R.3
Savelieva, I.4
Atar, D.5
Hohnloser, S.H.6
Hindricks, G.7
Kirchhof, P.8
-
4
-
-
34347394385
-
Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation
-
Hart RG, Pearce LA, Aguilar MI. Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.
-
(2007)
Ann Intern Med
, vol.146
, pp. 857-867
-
-
Hart, R.G.1
Pearce, L.A.2
Aguilar, M.I.3
-
5
-
-
84896117299
-
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials
-
Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials. Lancet 2014;383: 955-962.
-
(2014)
Lancet
, vol.383
, pp. 955-962
-
-
Ruff, C.T.1
Giugliano, R.P.2
Braunwald, E.3
Hoffman, E.B.4
Deenadayalu, N.5
Ezekowitz, M.D.6
Camm, A.J.7
Weitz, J.I.8
Lewis, B.S.9
Parkhomenko, A.10
Yamashita, T.11
Antman, E.M.12
-
6
-
-
84922255160
-
Heart failure and atrial fibrillation: From basic science to clinical practice
-
Ferreira JP, Santos M. Heart Failure and Atrial Fibrillation: From Basic Science to Clinical Practice. Int J Mol Sci 2015;16: 3133-3147.
-
(2015)
Int J Mol Sci
, vol.16
, pp. 3133-3147
-
-
Ferreira, J.P.1
Santos, M.2
-
7
-
-
0032497292
-
Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
-
Benjamin EJ,Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study. Circulation 1998;98: 946-952.
-
(1998)
Circulation
, vol.98
, pp. 946-952
-
-
Benjamin, E.J.1
Wolf, P.A.2
D'Agostino, R.B.3
Silbershatz, H.4
Kannel, W.B.5
Levy, D.6
-
8
-
-
0031686381
-
Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction
-
Dries DL, Exner DV, Gersh BJ, Domanski MJ,Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;32: 695-703.
-
(1998)
J Am Coll Cardiol
, vol.32
, pp. 695-703
-
-
Dries, D.L.1
Exner, D.V.2
Gersh, B.J.3
Domanski, M.J.4
Waclawiw, M.A.5
Stevenson, L.W.6
-
9
-
-
0037456855
-
Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy
-
Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: Epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003;91: 2d-8d.
-
(2003)
Am J Cardiol
, vol.91
, pp. 2d-8d
-
-
Maisel, W.H.1
Stevenson, L.W.2
-
10
-
-
0027998462
-
Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)
-
Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Lancet 1994;344: 493-498.
-
(1994)
Lancet
, vol.344
, pp. 493-498
-
-
Doval, H.C.1
Nul, D.R.2
Grancelli, H.O.3
Perrone, S.V.4
Bortman, G.R.5
Curiel, R.6
-
11
-
-
0027229344
-
The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The VHeFT Studies. The V-HeFT VA Cooperative Studies Group
-
Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The VHeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation 1993;87(6 Suppl): Vi102-Vi110.
-
(1993)
Circulation
, vol.87
, Issue.6
, pp. Vi102-Vi110
-
-
Carson, P.E.1
Johnson, G.R.2
Dunkman, W.B.3
Fletcher, R.D.4
Farrell, L.5
Cohn, J.N.6
-
12
-
-
0032497913
-
Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT
-
Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: Observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation 1998;98: 2574-2579.
-
(1998)
Circulation
, vol.98
, pp. 2574-2579
-
-
Deedwania, P.C.1
Singh, B.N.2
Ellenbogen, K.3
Fisher, S.4
Fletcher, R.5
Singh, S.N.6
-
13
-
-
0033575989
-
Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group
-
Torp-Pedersen C, Møller M, Bloch-Thomsen PE, Køber L, Sandøe E, Egstrup K, Agner E, Carlsen J, Videbaek J, Marchant B, Camm AJ. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med 1999;341: 857-865.
-
(1999)
N Engl J Med
, vol.341
, pp. 857-865
-
-
Torp-Pedersen, C.1
Møller, M.2
Bloch-Thomsen, P.E.3
Køber, L.4
Sandøe, E.5
Egstrup, K.6
Agner, E.7
Carlsen, J.8
Videbaek, J.9
Marchant, B.10
Camm, A.J.11
-
14
-
-
0023694997
-
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS
-
Swedberg K, Kjekshus J. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). Am J Cardiol 1988;62: 60A-66A.
-
(1988)
Am J Cardiol
, vol.62
, pp. 60A-66A
-
-
Swedberg, K.1
Kjekshus, J.2
-
15
-
-
84888362796
-
Edoxaban versus warfarin in patients with atrial fibrillation
-
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldon AL, Ezekowitz MD, Weitz JI, S?pinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013;369: 2093-2104.
-
(2013)
N Engl J Med
, vol.369
, pp. 2093-2104
-
-
Giugliano, R.P.1
Ruff, C.T.2
Braunwald, E.3
Murphy, S.A.4
Wiviott, S.D.5
Halperin, J.L.6
Waldon, A.L.7
Ezekowitz, M.D.8
Weitz, J.I.9
Spinar, J.10
Ruzyllo, W.11
Ruda, M.12
Koretsune, Y.13
Betcher, J.14
Shi, M.15
Grip, L.T.16
Patel, S.P.17
Patel, I.18
Hanyok, J.J.19
Mercuri, M.20
Antman, E.M.21
more..
-
16
-
-
84947866649
-
Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: The COMMANDER HF trial
-
Zannad F, Greenberg B, Cleland JG, Gheorghiade M, van Veldhuisen DJ, Mehra MR, Anker SD, Byra WM, Fu M, Mills RM. Rationale and design of a randomized, double-blind, event-driven, multicentre study comparing the efficacy and safety of oral rivaroxaban with placebo for reducing the risk of death, myocardial infarction or stroke in subjects with heart failure and significant coronary artery disease following an exacerbation of heart failure: The COMMANDER HF trial. Eur J Heart Fail 2015;17: 735-742.
-
(2015)
Eur J Heart Fail
, vol.17
, pp. 735-742
-
-
Zannad, F.1
Greenberg, B.2
Cleland, J.G.3
Gheorghiade, M.4
Van Veldhuisen, D.J.5
Mehra, M.R.6
Anker, S.D.7
Byra, W.M.8
Fu, M.9
Mills, R.M.10
-
17
-
-
77950481355
-
Atrial fibrillation in heart failure: A comprehensive review
-
Deedwania PC, Lardizabal JA. Atrial fibrillation in heart failure: A comprehensive review. Am J Med 2010;123: 198-204.
-
(2010)
Am J Med
, vol.123
, pp. 198-204
-
-
Deedwania, P.C.1
Lardizabal, J.A.2
-
18
-
-
0037635434
-
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study
-
Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP,Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003;107: 2920-2925.
-
(2003)
Circulation
, vol.107
, pp. 2920-2925
-
-
Wang, T.J.1
Larson, M.G.2
Levy, D.3
Vasan, R.S.4
Leip, E.P.5
Wolf, P.A.6
D'Agostino, R.B.7
Murabito, J.M.8
Kannel, W.B.9
Benjamin, E.J.10
-
19
-
-
84864477617
-
Developed in collaboration with the Heart Failure Association (HFA) of the ESC
-
Bax JJ Baumgartner H Ceconi C Dean V Deaton C Fagard R Funck-Brentano C Hasdai D Hoes A Kirchhof P Knuuti J Kolh P McDonagh T Moulin C Popescu BA Reiner Z Sechtem U Sirnes PA Tendera M Torbicki A Vahanian A Windecker S McDonagh T Sechtem U Bonet LA Avraamides P Ben Lamin HA Brignole M Coca A Cowburn P Dargie H Elliott P Flachskampf FA Guida GF Hardman S Iung B Merkely B Mueller C Nanas JN NielsenOW Orn S Parissis JT Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology
-
McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, NielsenOW, Orn S, Parissis JT, Ponikowski P. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14: 803-869.
-
(2012)
Eur J Heart Fail
, vol.14
, pp. 803-869
-
-
McMurray, J.J.1
Adamopoulos, S.2
Anker, S.D.3
Auricchio, A.4
Böhm, M.5
Dickstein, K.6
Falk, V.7
Filippatos, G.8
Fonseca, C.9
Gomez-Sanchez, M.A.10
Jaarsma, T.11
Køber, L.12
Lip, G.Y.13
Maggioni, A.P.14
Parkhomenko, A.15
Pieske, B.M.16
Popescu, B.A.17
Rønnevik, P.K.18
Rutten, F.H.19
Schwitter, J.20
Seferovic, P.21
Stepinska, J.22
Trindade, P.T.23
Voors, A.A.24
Zannad, F.25
Zeiher, A.26
more..
-
20
-
-
84898024964
-
Global burden of atrial fibrillation in developed and developing nations
-
Chugh SS, Roth GA, Gillum RF, Mensah GA. Global burden of atrial fibrillation in developed and developing nations. Glob Heart 2014;9: 113-119.
-
(2014)
Glob Heart
, vol.9
, pp. 113-119
-
-
Chugh, S.S.1
Roth, G.A.2
Gillum, R.F.3
Mensah, G.A.4
-
21
-
-
34147115631
-
Atrial fibrillation in heart failure patients: Prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry
-
De Ferrari GM, Klersy C, Ferrero P, Fantoni C, Salerno-Uriarte D, Manca L, Devecchi P, Molon G, Revera M, Curnis A, Sarzi Braga S, Accardi F, Salerno- Uriarte JA. Atrial fibrillation in heart failure patients: Prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry. Eur J Heart Fail 2007;9: 502-509.
-
(2007)
Eur J Heart Fail
, vol.9
, pp. 502-509
-
-
De Ferrari, G.M.1
Klersy, C.2
Ferrero, P.3
Fantoni, C.4
Salerno-Uriarte, D.5
Manca, L.6
Devecchi, P.7
Molon, G.8
Revera, M.9
Curnis, A.10
Sarzi Braga, S.11
Accardi, F.12
Salerno-Uriarte, J.A.13
-
22
-
-
84940426249
-
Residual risk of stroke and death in anticoagulated patients according to the type of atrial fibrillation: AMADEUS trial
-
Senoo K, Lip GY, Lane DA, Buller HR, Kotecha D. Residual risk of stroke and death in anticoagulated patients according to the type of atrial fibrillation: AMADEUS trial. Stroke 2015;46: 2523-2528.
-
(2015)
Stroke
, vol.46
, pp. 2523-2528
-
-
Senoo, K.1
Lip, G.Y.2
Lane, D.A.3
Buller, H.R.4
Kotecha, D.5
-
23
-
-
0030588930
-
Improving survival for patients with atrial fibrillation and advanced heart failure
-
Stevenson WG, Stevenson LW, Middlekauff HR, Fonarow GC, Hamilton MA, Woo MA, Saxon LA, Natterson PD, Steimle A,Walden JA, Tillisch JH. Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 1996;28: 1458-1463.
-
(1996)
J Am Coll Cardiol
, vol.28
, pp. 1458-1463
-
-
Stevenson, W.G.1
Stevenson, L.W.2
Middlekauff, H.R.3
Fonarow, G.C.4
Hamilton, M.A.5
Woo, M.A.6
Saxon, L.A.7
Natterson, P.D.8
Steimle, A.9
Walden, J.A.10
Tillisch, J.H.11
-
24
-
-
84962009900
-
-
Document Reviewers: Gorenek B, Lane D, Boriani G, Linde C, Hindricks G, Tsutsui H, Homma S, Brownstein S, Nielsen JC, Lainscak M, Crespo-Leiro M, Piepoli M, Seferovic P, Savelieva I. European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
-
Lip GY, Heinzel FR, Gaita F, Juanatey JR, Le Heuzey JY, Potpara T, Svendsen JH, Vos MA, Anker SD, Coats AJ, Haverkamp W, Manolis AS, Chung MK, Sanders P, Pieske B; Document Reviewers: Gorenek B, Lane D, Boriani G, Linde C, Hindricks G, Tsutsui H, Homma S, Brownstein S, Nielsen JC, Lainscak M, Crespo-Leiro M, Piepoli M, Seferovic P, Savelieva I. European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace 2016;18: 12-36.
-
(2016)
Europace
, vol.18
, pp. 12-36
-
-
Lip, G.Y.1
Heinzel, F.R.2
Gaita, F.3
Juanatey, J.R.4
Le Heuzey, J.Y.5
Potpara, T.6
Svendsen, J.H.7
Vos, M.A.8
Anker, S.D.9
Coats, A.J.10
Haverkamp, W.11
Manolis, A.S.12
Chung, M.K.13
Sanders, P.14
Pieske, B.15
-
25
-
-
84920001478
-
Prognosis and treatment of atrial fibrillation patients by European cardiologists: One year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry
-
Lip GY, Laroche C, Ioachim PM, Rasmussen LH, Vitali-Serdoz L, Petrescu L, Darabantiu D, Crijns HJ, Kirchhof P, Vardas P, Tavazzi L, Maggioni AP, Boriani G. Prognosis and treatment of atrial fibrillation patients by European cardiologists: One year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry). Eur Heart J 2014;35: 3365-3376.
-
(2014)
Eur Heart J
, vol.35
, pp. 3365-3376
-
-
Lip, G.Y.1
Laroche, C.2
Ioachim, P.M.3
Rasmussen, L.H.4
Vitali-Serdoz, L.5
Petrescu, L.6
Darabantiu, D.7
Crijns, H.J.8
Kirchhof, P.9
Vardas, P.10
Tavazzi, L.11
Maggioni, A.P.12
Boriani, G.13
-
27
-
-
84862909359
-
Subclinical atrial fibrillation and the risk of stroke
-
Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366: 120-129.
-
(2012)
N Engl J Med
, vol.366
, pp. 120-129
-
-
Healey, J.S.1
Connolly, S.J.2
Gold, M.R.3
Israel, C.W.4
Van Gelder, I.C.5
Capucci, A.6
Lau, C.P.7
Fain, E.8
Yang, S.9
Bailleul, C.10
Morillo, C.A.11
Carlson, M.12
Themeles, E.13
Kaufman, E.S.14
Hohnloser, S.H.15
-
28
-
-
34548414621
-
Minimizing ventricular pacing to reduce atrial fibrillation in sinusnode disease
-
Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D, Sheldon T, Lamas GA. Minimizing ventricular pacing to reduce atrial fibrillation in sinusnode disease. N Engl J Med 2007;357: 1000-1008.
-
(2007)
N Engl J Med
, vol.357
, pp. 1000-1008
-
-
Sweeney, M.O.1
Bank, A.J.2
Nsah, E.3
Koullick, M.4
Zeng, Q.C.5
Hettrick, D.6
Sheldon, T.7
Lamas, G.A.8
-
29
-
-
84964695741
-
Higher risk of death and stroke in patients with persistent vs. Paroxysmal atrial fibrillation: Results from the ROCKETAF Trial
-
Steinberg BA, Hellkamp AS, Lokhnygina Y, Patel MR, Breithardt G, Hankey GJ, Becker RC, Singer DE, Halperin JL, Hacke W, Nessel CC, Berkowitz SD, Mahaffey KW, Fox KA, Califf RM, Piccini JP. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: Results from the ROCKETAF Trial. Eur Heart J 2015;36: 288-296.
-
(2015)
Eur Heart J
, vol.36
, pp. 288-296
-
-
Steinberg, B.A.1
Hellkamp, A.S.2
Lokhnygina, Y.3
Patel, M.R.4
Breithardt, G.5
Hankey, G.J.6
Becker, R.C.7
Singer, D.E.8
Halperin, J.L.9
Hacke, W.10
Nessel, C.C.11
Berkowitz, S.D.12
Mahaffey, K.W.13
Fox, K.A.14
Califf, R.M.15
Piccini, J.P.16
-
30
-
-
84922381210
-
Heart disease and stroke statistics-2015 update: A report from the American Heart Association
-
Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER III, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation 2015;131: E29-322.
-
(2015)
Circulation
, vol.131
, pp. e29-e322
-
-
Mozaffarian, D.1
Benjamin, E.J.2
Go, A.S.3
Arnett, D.K.4
Blaha, M.J.5
Cushman, M.6
De Ferranti, S.7
Després, J.P.8
Fullerton, H.J.9
Howard, V.J.10
Huffman, M.D.11
Judd, S.E.12
Kissela, B.M.13
Lackland, D.T.14
Lichtman, J.H.15
Lisabeth, L.D.16
Liu, S.17
Mackey, R.H.18
Matchar, D.B.19
McGuire, D.K.20
Mohler, E.R.21
Moy, C.S.22
Muntner, P.23
Mussolino, M.E.24
Nasir, K.25
Neumar, R.W.26
Nichol, G.27
Palaniappan, L.28
Pandey, D.K.29
Reeves, M.J.30
Rodriguez, C.J.31
Sorlie, P.D.32
Stein, J.33
Towfighi, A.34
Turan, T.N.35
Virani, S.S.36
Willey, J.Z.37
Woo, D.38
Yeh, R.W.39
Turner, M.B.40
more..
-
31
-
-
84908220640
-
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
-
January CT,Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, Conti JB, Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, Tracy CM, Yancy CW. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014;64: E1-76.
-
(2014)
J Am Coll Cardiol
, vol.64
, pp. e1-e76
-
-
January, C.T.1
Wann, L.S.2
Alpert, J.S.3
Calkins, H.4
Cigarroa, J.E.5
Cleveland, J.C.6
Conti, J.B.7
Ellinor, P.T.8
Ezekowitz, M.D.9
Field, M.E.10
Murray, K.T.11
Sacco, R.L.12
Stevenson, W.G.13
Tchou, P.J.14
Tracy, C.M.15
Yancy, C.W.16
-
32
-
-
85045802678
-
Randomized trial of anticoagulation guided by remote rhythm monitoring in patients with implanted cardioverter-defibrillator and resynchronization devices
-
Washington, DC: 29 March
-
Ip J, Waldo AL, Lip GY, Rothwell PM, Martin DT, Bersohn MM, Choucair WK, Akar JG, Wathen MS, Rohani P, Halperin JL. Randomized trial of anticoagulation guided by remote rhythm monitoring in patients with implanted cardioverter-defibrillator and resynchronization devices. In: ACC 63rd Annual Scientific Sessions and Expo. Washington, DC: 29 March 2014.
-
(2014)
ACC 63rd Annual Scientific Sessions and Expo
-
-
Ip, J.1
Waldo, A.L.2
Lip, G.Y.3
Rothwell, P.M.4
Martin, D.T.5
Bersohn, M.M.6
Choucair, W.K.7
Akar, J.G.8
Wathen, M.S.9
Rohani, P.10
Halperin, J.L.11
-
33
-
-
84942409774
-
Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices
-
Martin DT, Bersohn MM, Waldo AL, Wathen MS, Choucair WK, Lip GY, Ip J, Holcomb R, Akar JG, Halperin JL. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J 2015;36: 1660-1668.
-
(2015)
Eur Heart J
, vol.36
, pp. 1660-1668
-
-
Martin, D.T.1
Bersohn, M.M.2
Waldo, A.L.3
Wathen, M.S.4
Choucair, W.K.5
Lip, G.Y.6
Ip, J.7
Holcomb, R.8
Akar, J.G.9
Halperin, J.L.10
-
34
-
-
84903434770
-
Heart-rhythm monitoring for evaluation of cryptogenic stroke
-
Kamel H. Heart-rhythm monitoring for evaluation of cryptogenic stroke. N Engl J Med 2014;370: 2532-2533.
-
(2014)
N Engl J Med
, vol.370
, pp. 2532-2533
-
-
Kamel, H.1
-
35
-
-
84903446651
-
Atrial fibrillation in patients with cryptogenic stroke
-
Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O'Donnell M, Laupacis A, CotéR, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S, Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K, Aviv R, Kapral MK, Mamdani M. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014;370: 2467-2477.
-
(2014)
N Engl J Med
, vol.370
, pp. 2467-2477
-
-
Gladstone, D.J.1
Spring, M.2
Dorian, P.3
Panzov, V.4
Thorpe, K.E.5
Hall, J.6
Vaid, H.7
O'Donnell, M.8
Laupacis, A.9
Côté, R.10
Sharma, M.11
Blakely, J.A.12
Shuaib, A.13
Hachinski, V.14
Coutts, S.B.15
Sahlas, D.J.16
Teal, P.17
Yip, S.18
Spence, J.D.19
Buck, B.20
Verreault, S.21
Casaubon, L.K.22
Penn, A.23
Selchen, D.24
Jin, A.25
Howse, D.26
Mehdiratta, M.27
Boyle, K.28
Aviv, R.29
Kapral, M.K.30
Mamdani, M.31
more..
-
36
-
-
84903485570
-
Cryptogenic stroke and underlying atrial fibrillation
-
Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014;370: 2478-2486.
-
(2014)
N Engl J Med
, vol.370
, pp. 2478-2486
-
-
Sanna, T.1
Diener, H.C.2
Passman, R.S.3
Di Lazzaro, V.4
Bernstein, R.A.5
Morillo, C.A.6
Rymer, M.M.7
Thijs, V.8
Rogers, T.9
Beckers, F.10
Lindborg, K.11
Brachmann, J.12
-
37
-
-
0035854054
-
Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation
-
Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001;285: 2864-2870.
-
(2001)
JAMA
, vol.285
, pp. 2864-2870
-
-
Gage, B.F.1
Waterman, A.D.2
Shannon, W.3
Boechler, M.4
Rich, M.W.5
Radford, M.J.6
-
38
-
-
76749163232
-
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation
-
Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest 2010; 137: 263-272.
-
(2010)
Chest
, vol.137
, pp. 263-272
-
-
Lip, G.Y.1
Nieuwlaat, R.2
Pisters, R.3
Lane, D.A.4
Crijns, H.J.5
-
39
-
-
77954392300
-
The CHADS2 score for stroke risk stratification in atrial fibrillation-friend or foe?
-
Karthikeyan G, Eikelboom JW. The CHADS2 score for stroke risk stratification in atrial fibrillation-friend or foe? Thromb Haemost 2010;104: 45-48.
-
(2010)
Thromb Haemost
, vol.104
, pp. 45-48
-
-
Karthikeyan, G.1
Eikelboom, J.W.2
-
40
-
-
84884375827
-
A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: The ATRIA study stroke risk score
-
Singer DE, Chang Y, Borowsky LH, Fang MC, Pomernacki NK, Udaltsova N, Reynolds K, Go AS. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: The ATRIA study stroke risk score. J Am Heart Assoc 2013;2: E000250.
-
(2013)
J Am Heart Assoc
, vol.2
, pp. e000250
-
-
Singer, D.E.1
Chang, Y.2
Borowsky, L.H.3
Fang, M.C.4
Pomernacki, N.K.5
Udaltsova, N.6
Reynolds, K.7
Go, A.S.8
-
41
-
-
84945978079
-
Comparative performance of ATRIA, CHADS2, and CHA2DS2-VASc risk scores predicting stroke in patients with atrial fibrillation: Results from a national primary care database
-
van den Ham HA, Klungel OH, Singer DE, Leufkens HG, van Staa TP. Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database. J Am Coll Cardiol 2015;66: 1851-1859.
-
(2015)
J Am Coll Cardiol
, vol.66
, pp. 1851-1859
-
-
Van Den Ham, H.A.1
Klungel, O.H.2
Singer, D.E.3
Leufkens, H.G.4
Van Staa, T.P.5
-
42
-
-
84947779709
-
Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation
-
Abumuaileq RR, Abu-Assi E, Lopez-Lopez A, Raposeiras-Roubin S, Rodriguez- Manero M, Martinez-Sande L. Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation. BMC Cardiovasc Disord 2015;15: 156.
-
(2015)
BMC Cardiovasc Disord
, vol.15
, pp. 156
-
-
Abumuaileq, R.R.1
Abu-Assi, E.2
Lopez-Lopez, A.3
Raposeiras-Roubin, S.4
Rodriguez-Manero, M.5
Martinez-Sande, L.6
-
43
-
-
84907969698
-
Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation
-
Chao TF, Liu CJ, Wang KL, Lin YJ, Chang SL, Lo LW. Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation. J Am Coll Cardiol 2014;64: 1658-1665.
-
(2014)
J Am Coll Cardiol
, vol.64
, pp. 1658-1665
-
-
Chao, T.F.1
Liu, C.J.2
Wang, K.L.3
Lin, Y.J.4
Chang, S.L.5
Lo, L.W.6
-
44
-
-
84941625442
-
Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation
-
Melgaard L, Gorst-Rasmussen A, Lane DA, Rasmussen LH, Larsen TB, Lip GY. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation. JAMA 2015;314: 1030-1038.
-
(2015)
JAMA
, vol.314
, pp. 1030-1038
-
-
Melgaard, L.1
Gorst-Rasmussen, A.2
Lane, D.A.3
Rasmussen, L.H.4
Larsen, T.B.5
Lip, G.Y.6
-
45
-
-
34548455445
-
Independent predictors of stroke in patients with atrial fibrillation: A systematic review
-
Melgaard L. Independent predictors of stroke in patients with atrial fibrillation: A systematic review. Neurology 2007;69: 546-554.
-
(2007)
Neurology
, vol.69
, pp. 546-554
-
-
Melgaard, L.1
-
46
-
-
84929297023
-
Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure
-
Sandhu RK, Hohnloser SH, Pfeffer MA, Yuan F, Hart RG, Yusuf S, Connolly SJ, McAlister FA, Healey JS. Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure. Stroke 2015;46: 667-672.
-
(2015)
Stroke
, vol.46
, pp. 667-672
-
-
Sandhu, R.K.1
Hohnloser, S.H.2
Pfeffer, M.A.3
Yuan, F.4
Hart, R.G.5
Yusuf, S.6
Connolly, S.J.7
McAlister, F.A.8
Healey, J.S.9
-
47
-
-
84879197579
-
Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: Insights from the Aristotle trial
-
McMurray JJ, Ezekowitz JA, Lewis BS, Gersh BJ, van Diepen S, Amerena J, Bartunek J, Commerford P, Oh BH, Harjola VP, Al-Khatib SM, Hanna M, Alexander JH, Lopes RD,Wojdyla DM,Wallentin L, Granger CB. Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: Insights from the ARISTOTLE trial. Circ Heart Fail 2013;6: 451-460.
-
(2013)
Circ Heart Fail
, vol.6
, pp. 451-460
-
-
McMurray, J.J.1
Ezekowitz, J.A.2
Lewis, B.S.3
Gersh, B.J.4
Van Diepen, S.5
Amerena, J.6
Bartunek, J.7
Commerford, P.8
Oh, B.H.9
Harjola, V.P.10
Al-Khatib, S.M.11
Hanna, M.12
Alexander, J.H.13
Lopes, R.D.14
Wojdyla, D.M.15
Wallentin, L.16
Granger, C.B.17
-
48
-
-
80054712170
-
Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction
-
Badheka AO, Rathod A, Kizilbash MA, Bhardwaj A, Ali O, Afonso L, Jacob S. Comparison of mortality and morbidity in patients with atrial fibrillation and heart failure with preserved versus decreased left ventricular ejection fraction. Am J Cardiol 2011;108: 1283-1288.
-
(2011)
Am J Cardiol
, vol.108
, pp. 1283-1288
-
-
Badheka, A.O.1
Rathod, A.2
Kizilbash, M.A.3
Bhardwaj, A.4
Ali, O.5
Afonso, L.6
Jacob, S.7
-
49
-
-
33646254610
-
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program
-
Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: Results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 2006;47: 1997-2004.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 1997-2004
-
-
Olsson, L.G.1
Swedberg, K.2
Ducharme, A.3
Granger, C.B.4
Michelson, E.L.5
McMurray, J.J.6
Puu, M.7
Yusuf, S.8
Pfeffer, M.A.9
-
50
-
-
34547693119
-
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial
-
Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, Murray E.Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomised controlled trial. Lancet 2007;370: 493-503.
-
(2007)
Lancet
, vol.370
, pp. 493-503
-
-
Mant, J.1
Hobbs, F.D.2
Fletcher, K.3
Roalfe, A.4
Fitzmaurice, D.5
Lip, G.Y.6
Murray, E.7
-
51
-
-
78649342646
-
Patient characteristics associated with oral anticoagulation control: Results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA
-
Rose AJ, Hylek EM, Ozonoff A, Ash AS, Reisman JI, Berlowitz DR. Patient characteristics associated with oral anticoagulation control: Results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA). J Thromb Haemost 2010;8: 2182-2191.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 2182-2191
-
-
Rose, A.J.1
Hylek, E.M.2
Ozonoff, A.3
Ash, A.S.4
Reisman, J.I.5
Berlowitz, D.R.6
-
52
-
-
78650878679
-
Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score
-
Lip GY, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: The HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol 2011;57: 173-180.
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 173-180
-
-
Lip, G.Y.1
Frison, L.2
Halperin, J.L.3
Lane, D.A.4
-
53
-
-
17044428901
-
Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
-
DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149: 650-656.
-
(2005)
Am Heart J
, vol.149
, pp. 650-656
-
-
DiMarco, J.P.1
Flaker, G.2
Waldo, A.L.3
Corley, S.D.4
Greene, H.L.5
Safford, R.E.6
-
54
-
-
70349254549
-
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
-
Witt DM, Delate T, Clark NP, Martell C, Tran T, Crowther MA, Garcia DA, AgenoW, Hylek EM. Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood 2009;114: 952-956.
-
(2009)
Blood
, vol.114
, pp. 952-956
-
-
Witt, D.M.1
Delate, T.2
Clark, N.P.3
Martell, C.4
Tran, T.5
Crowther, M.A.6
Garcia, D.A.7
Ageno, W.8
Hylek, E.M.9
-
55
-
-
77952728946
-
Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users
-
Witt DM, Delate T, Clark NP, Martell C, Tran T, Crowther MA, Garcia DA, Ageno W, Hylek EM. Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users. J Thromb Haemost 2010;8: 744-749.
-
(2010)
J Thromb Haemost
, vol.8
, pp. 744-749
-
-
Witt, D.M.1
Delate, T.2
Clark, N.P.3
Martell, C.4
Tran, T.5
Crowther, M.A.6
Garcia, D.A.7
Ageno, W.8
Hylek, E.M.9
-
56
-
-
80052094564
-
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
-
Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol 2011;58: 395-401.
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 395-401
-
-
Fang, M.C.1
Go, A.S.2
Chang, Y.3
Borowsky, L.H.4
Pomernacki, N.K.5
Udaltsova, N.6
Singer, D.E.7
-
57
-
-
33344461585
-
Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF
-
Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW. Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006;151: 713-719.
-
(2006)
Am Heart J
, vol.151
, pp. 713-719
-
-
Gage, B.F.1
Yan, Y.2
Milligan, P.E.3
Waterman, A.D.4
Culverhouse, R.5
Rich, M.W.6
-
58
-
-
46749145855
-
Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry
-
Ruiz-Gimenez N, Suarez C, Gonzalez R, Nieto JA, Todoli JA, Samperiz AL. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008;100: 26-31.
-
(2008)
Thromb Haemost
, vol.100
, pp. 26-31
-
-
Ruiz-Gimenez, N.1
Suarez, C.2
Gonzalez, R.3
Nieto, J.A.4
Todoli, J.A.5
Samperiz, A.L.6
-
59
-
-
77955872745
-
A novel userfriendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey
-
Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel userfriendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest 2010;138: 1093-1100.
-
(2010)
Chest
, vol.138
, pp. 1093-1100
-
-
Pisters, R.1
Lane, D.A.2
Nieuwlaat, R.3
De Vos, C.B.4
Crijns, H.J.5
Lip, G.Y.6
-
60
-
-
80055079237
-
Risk of bleeding with oral anticoagulants: An updated systematic review and performance analysis of clinical prediction rules
-
Loewen P, Dahri K. Risk of bleeding with oral anticoagulants: An updated systematic review and performance analysis of clinical prediction rules. Ann Hematol 2011;90: 1191-1200.
-
(2011)
Ann Hematol
, vol.90
, pp. 1191-1200
-
-
Loewen, P.1
Dahri, K.2
-
61
-
-
84865292043
-
Performance of the HEMORR( 2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: The AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study
-
Apostolakis S, Lane DA, Guo Y, Buller H, Lip GY. Performance of the HEMORR( 2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: The AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. J Am Coll Cardiol 2012;60: 861-867.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 861-867
-
-
Apostolakis, S.1
Lane, D.A.2
Guo, Y.3
Buller, H.4
Lip, G.Y.5
-
62
-
-
84883747848
-
Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarin
-
Burgess S, Crown N, Louzada ML, Dresser G, Kim RB, Lazo-Langner A. Clinical performance of bleeding risk scores for predicting major and clinically relevant non-major bleeding events in patients receiving warfarin. J Thromb Haemost 2013;11: 1647-1654.
-
(2013)
J Thromb Haemost
, vol.11
, pp. 1647-1654
-
-
Burgess, S.1
Crown, N.2
Louzada, M.L.3
Dresser, G.4
Kim, R.B.5
Lazo-Langner, A.6
-
63
-
-
84901924134
-
Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation
-
Cameron C, Coyle D, Richter T, Kelly S, Gauthier K, Steiner S. Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation. BMJ Open 2014; 4: E004301.
-
(2014)
BMJ Open
, vol.4
, pp. e004301
-
-
Cameron, C.1
Coyle, D.2
Richter, T.3
Kelly, S.4
Gauthier, K.5
Steiner, S.6
-
64
-
-
84937970837
-
Bleeding risk, management and outcome in patients receiving non-VKA oral anticoagulants (NOACs
-
Werth S, Breslin T, NiAinle F, Beyer-Westendorf J. Bleeding risk, management and outcome in patients receiving non-VKA oral anticoagulants (NOACs). Am J Cardiovasc Drugs 2015;15: 235-242.
-
(2015)
Am J Cardiovasc Drugs
, vol.15
, pp. 235-242
-
-
Werth, S.1
Breslin, T.2
NiAinle, F.3
Beyer-Westendorf, J.4
-
65
-
-
0032144231
-
Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
-
Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998; 105: 91-99.
-
(1998)
Am J Med
, vol.105
, pp. 91-99
-
-
Beyth, R.J.1
Quinn, L.M.2
Landefeld, C.S.3
-
66
-
-
0031470151
-
Major haemorrhagic complications during oral anticoagulant therapy in a Danish populationbased cohort
-
Steffensen FH, Kristensen K, Ejlersen E, Dahlerup JF, Sorensen HT. Major haemorrhagic complications during oral anticoagulant therapy in a Danish populationbased cohort. J Intern Med 1997;242: 497-503.
-
(1997)
J Intern Med
, vol.242
, pp. 497-503
-
-
Steffensen, F.H.1
Kristensen, K.2
Ejlersen, E.3
Dahlerup, J.F.4
Sorensen, H.T.5
-
67
-
-
84873326583
-
Rates of hemorrhage during warfarin therapy for atrial fibrillation
-
Gomes T, Mamdani MM, Holbrook AM, Paterson JM, Hellings C, Juurlink DN. Rates of hemorrhage during warfarin therapy for atrial fibrillation. CMAJ 2013; 185: E121-E127.
-
(2013)
CMAJ
, vol.185
, pp. E121-E127
-
-
Gomes, T.1
Mamdani, M.M.2
Holbrook, A.M.3
Paterson, J.M.4
Hellings, C.5
Juurlink, D.N.6
-
68
-
-
41349089568
-
Management of atrial fibrillation in patients with heart failure
-
Efremidis M, Pappas L, Sideris A, Filippatos G. Management of atrial fibrillation in patients with heart failure. J Card Fail 2008;14: 232-237.
-
(2008)
J Card Fail
, vol.14
, pp. 232-237
-
-
Efremidis, M.1
Pappas, L.2
Sideris, A.3
Filippatos, G.4
-
69
-
-
84901375349
-
Dabigatran, rivaroxaban, or apixaban versus warfarin in patients with nonvalvular atrial fibrillation: A systematic eeview and meta-analysis of subgroups
-
Gomez-Outes A, Terleira-Fernandez AI, Calvo-Rojas G, Suarez-Gea ML, Vargas- Castrillon E. Dabigatran, rivaroxaban, or apixaban versus warfarin in patients with nonvalvular atrial fibrillation: A systematic eeview and meta-analysis of subgroups. Thrombosis 2013;2013: 640723.
-
(2013)
Thrombosis
, vol.2013
, pp. 640723
-
-
Gomez-Outes, A.1
Terleira-Fernandez, A.I.2
Calvo-Rojas, G.3
Suarez-Gea, M.L.4
Vargas-Castrillon, E.5
-
70
-
-
84869501537
-
Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: Findings from the ADHERE registry linked to Medicare claims
-
Hess PL, Greiner MA, Fonarow GC, KlaskalaW, Mills RM, Setoguchi S. Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: Findings from the ADHERE registry linked to Medicare claims. Clin Cardiol 2012;35: 649-657.
-
(2012)
Clin Cardiol
, vol.35
, pp. 649-657
-
-
Hess, P.L.1
Greiner, M.A.2
Fonarow, G.C.3
KlaskalaW Mills, R.M.4
Setoguchi, S.5
-
71
-
-
84883171753
-
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: A subgroup analysis of the RE-LY trial
-
Ferreira J, Ezekowitz MD, Connolly SJ, Brueckmann M, Fraessdorf M, Reilly PA, Yusuf S, Wallentin L. Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: A subgroup analysis of the RE-LY trial. Eur J Heart Fail 2013;15: 1053-1061.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 1053-1061
-
-
Ferreira, J.1
Ezekowitz, M.D.2
Connolly, S.J.3
Brueckmann, M.4
Fraessdorf, M.5
Reilly, P.A.6
Yusuf, S.7
Wallentin, L.8
-
72
-
-
84883169110
-
Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: Insights from ROCKET AF
-
van Diepen S, Hellkamp AS, Patel MR, Becker RC, Breithardt G, Hacke W, Halperin JL, Hankey GJ, Nessel CC, Singer DE, Berkowitz SD, Califf RM, Fox KA, Mahaffey KW. Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: Insights from ROCKET AF. Circ Heart Fail 2013;6: 740-747.
-
(2013)
Circ Heart Fail
, vol.6
, pp. 740-747
-
-
Van Diepen, S.1
Hellkamp, A.S.2
Patel, M.R.3
Becker, R.C.4
Breithardt, G.5
Hacke, W.6
Halperin, J.L.7
Hankey, G.J.8
Nessel, C.C.9
Singer, D.E.10
Berkowitz, S.D.11
Califf, R.M.12
Fox, K.A.13
Mahaffey, K.W.14
-
73
-
-
84933586065
-
Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: Insights from Engage-AF TIMI
-
Abstract 12680
-
Magnani G, Giugliano RP, Ruff CT, Murphy SA, Nordio F, Rutman H. Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: Insights from Engage-AF TIMI 48. Circulation 2014; Abstract 12680.
-
(2014)
Circulation
, vol.48
-
-
Magnani, G.1
Giugliano, R.P.2
Ruff, C.T.3
Murphy, S.A.4
Nordio, F.5
Rutman, H.6
-
75
-
-
84915751170
-
Effect of renal function on prognosis in chronic heart failure
-
Loffler AI, Cappola TP, Fang J, Hetzel SJ, Kadlec A, Astor B. Effect of renal function on prognosis in chronic heart failure. Am J Cardiol 2015;115: 62-68.
-
(2015)
Am J Cardiol
, vol.115
, pp. 62-68
-
-
Loffler, A.I.1
Cappola, T.P.2
Fang, J.3
Hetzel, S.J.4
Kadlec, A.5
Astor, B.6
-
76
-
-
80052825103
-
Apixaban versus warfarin in patients with atrial fibrillation
-
Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al- Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez- Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J,Wallentin L. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365: 981-992.
-
(2011)
N Engl J Med
, vol.365
, pp. 981-992
-
-
Granger, C.B.1
Alexander, J.H.2
McMurray, J.J.3
Lopes, R.D.4
Hylek, E.M.5
Hanna, M.6
Al-Khalidi, H.R.7
Ansell, J.8
Atar, D.9
Avezum, A.10
Bahit, M.C.11
Diaz, R.12
Easton, J.D.13
Ezekowitz, J.A.14
Flaker, G.15
Garcia, D.16
Geraldes, M.17
Gersh, B.J.18
Golitsyn, S.19
Goto, S.20
Hermosillo, A.G.21
Hohnloser, S.H.22
Horowitz, J.23
Mohan, P.24
Jansky, P.25
Lewis, B.S.26
Lopez-Sendon, J.L.27
Pais, P.28
Parkhomenko, A.29
Verheugt, F.W.30
Zhu, J.31
Wallentin, L.32
more..
-
77
-
-
80052592404
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
-
Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365: 883-891.
-
(2011)
N Engl J Med
, vol.365
, pp. 883-891
-
-
Patel, M.R.1
Mahaffey, K.W.2
Garg, J.3
Pan, G.4
Singer, D.E.5
Hacke, W.6
Breithardt, G.7
Halperin, J.L.8
Hankey, G.J.9
Piccini, J.P.10
Becker, R.C.11
Nessel, C.C.12
Paolini, J.F.13
Berkowitz, S.D.14
Fox, K.A.15
Califf, R.M.16
-
78
-
-
70349306707
-
Dabigatran versus warfarin in patients with atrial fibrillation
-
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD,Wallentin L. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361: 1139-1151.
-
(2009)
N Engl J Med
, vol.361
, pp. 1139-1151
-
-
Connolly, S.J.1
Ezekowitz, M.D.2
Yusuf, S.3
Eikelboom, J.4
Oldgren, J.5
Parekh, A.6
Pogue, J.7
Reilly, P.A.8
Themeles, E.9
Varrone, J.10
Wang, S.11
Alings, M.12
Xavier, D.13
Zhu, J.14
Diaz, R.15
Lewis, B.S.16
Darius, H.17
Diener, H.C.18
Joyner, C.D.19
Wallentin, L.20
more..
-
79
-
-
84871481386
-
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: A subgroup analysis of the RE-LY trial
-
Abstract 10956
-
Ferreira J, Ezekowitz MD, Connolly SJ, Reilly PA, Clemens A, Brueckmann M. Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: A subgroup analysis of the RE-LY trial. Circulation 2011;Abstract 10956.
-
(2011)
Circulation
-
-
Ferreira, J.1
Ezekowitz, M.D.2
Connolly, S.J.3
Reilly, P.A.4
Clemens, A.5
Brueckmann, M.6
-
80
-
-
84955215646
-
Non-Vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: A systemic review and meta-analysis of randomized trials
-
Xiong Q, Lau YC, Senoo K, Lane DA, Hong K, Lip GY. Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: A systemic review and meta-analysis of randomized trials. Eur J Heart Fail 2015;17: 1192-1200.
-
(2015)
Eur J Heart Fail
, vol.17
, pp. 1192-1200
-
-
Xiong, Q.1
Lau, Y.C.2
Senoo, K.3
Lane, D.A.4
Hong, K.5
Lip, G.Y.6
-
81
-
-
4444256649
-
Quantifying the heart failure epidemic: Prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study
-
Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW. Quantifying the heart failure epidemic: Prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 2004;25: 1614-1619.
-
(2004)
Eur Heart J
, vol.25
, pp. 1614-1619
-
-
Bleumink, G.S.1
Knetsch, A.M.2
Sturkenboom, M.C.3
Straus, S.M.4
Hofman, A.5
Deckers, J.W.6
-
82
-
-
84896109810
-
Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: Results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF
-
Rossignol P, Dobre D, McMurray JJ, Swedberg K, Krum H, van Veldhuisen DJ, Shi H, Messig M, Vincent J, Girerd N, Bakris G, Pitt B, Zannad F. Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: Results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF). Circ Heart Fail 2014;7: 51-58.
-
(2014)
Circ Heart Fail
, vol.7
, pp. 51-58
-
-
Rossignol, P.1
Dobre, D.2
McMurray, J.J.3
Swedberg, K.4
Krum, H.5
Van Veldhuisen, D.J.6
Shi, H.7
Messig, M.8
Vincent, J.9
Girerd, N.10
Bakris, G.11
Pitt, B.12
Zannad, F.13
-
83
-
-
68349151861
-
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial
-
Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial. Lancet 2009;374: 534-542.
-
(2009)
Lancet
, vol.374
, pp. 534-542
-
-
Holmes, D.R.1
Reddy, V.Y.2
Turi, Z.G.3
Doshi, S.K.4
Sievert, H.5
Buchbinder, M.6
Mullin, C.M.7
Sick, P.8
-
84
-
-
84874001138
-
Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial
-
Reddy VY, Doshi SK, Sievert H, Buchbinder M, Neuzil P, Huber K. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation 2013;127: 720-729.
-
(2013)
Circulation
, vol.127
, pp. 720-729
-
-
Reddy, V.Y.1
Doshi, S.K.2
Sievert, H.3
Buchbinder, M.4
Neuzil, P.5
Huber, K.6
-
85
-
-
79751531253
-
Safety of percutaneous left atrial appendage closure: Results from theWatchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry
-
Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: Results from theWatchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011;123: 417-424.
-
(2011)
Circulation
, vol.123
, pp. 417-424
-
-
Reddy, V.Y.1
Holmes, D.2
Doshi, S.K.3
Neuzil, P.4
Kar, S.5
-
86
-
-
84903828960
-
Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial
-
Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. J Am Coll Cardiol 2014;64: 1-12.
-
(2014)
J Am Coll Cardiol
, vol.64
, pp. 1-12
-
-
Holmes, D.R.1
Kar, S.2
Price, M.J.3
Whisenant, B.4
Sievert, H.5
Doshi, S.K.6
Huber, K.7
Reddy, V.Y.8
-
87
-
-
84911388134
-
Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: A randomized clinical trial
-
Reddy VY, Sievert H, Halperin J, Doshi SK, Buchbinder M, Neuzil P. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: A randomized clinical trial. JAMA 2014;312: 1988-1998.
-
(2014)
JAMA
, vol.312
, pp. 1988-1998
-
-
Reddy, V.Y.1
Sievert, H.2
Halperin, J.3
Doshi, S.K.4
Buchbinder, M.5
Neuzil, P.6
-
88
-
-
84931026720
-
Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: A patient-level meta-analysis
-
Holmes DR Jr, Doshi SK, Kar S, Price MJ, Sanchez JM, Sievert H. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation: A patient-level meta-analysis. J Am Coll Cardiol 2015;65: 2614-2623.
-
(2015)
J Am Coll Cardiol
, vol.65
, pp. 2614-2623
-
-
Holmes, D.R.1
Doshi, S.K.2
Kar, S.3
Price, M.J.4
Sanchez, J.M.5
Sievert, H.6
-
89
-
-
33144465561
-
Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): Rationale, objectives, and design
-
Pullicino P, Thompson JL, Barton B, Levin B, Graham S, Freudenberger RS. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): Rationale, objectives, and design. J Card Fail 2006;12: 39-46.
-
(2006)
J Card Fail
, vol.12
, pp. 39-46
-
-
Pullicino, P.1
Thompson, J.L.2
Barton, B.3
Levin, B.4
Graham, S.5
Freudenberger, R.S.6
-
90
-
-
84929359318
-
Risk of stroke in chronic heart failure patients without atrial fibrillation: Analysis of the controlled rosuvastatin in multinational trial heart failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca- Heart Failure (GISSI-HF) trials
-
Wikstrand J, Kjekshus J, Lip GY, Maggioni AP, Tavazzi L, Lees KR, McMurray JJ. Risk of stroke in chronic heart failure patients without atrial fibrillation: Analysis of the controlled rosuvastatin in multinational trial heart failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca- Heart Failure (GISSI-HF) trials. Circulation 2015;131: 1486-1494.
-
(2015)
Circulation
, vol.131
, pp. 1486-1494
-
-
Wikstrand, J.1
Kjekshus, J.2
Lip, G.Y.3
Maggioni, A.P.4
Tavazzi, L.5
Lees, K.R.6
McMurray, J.J.7
-
91
-
-
1842295207
-
Ventricular dysfunction and the risk of stroke after myocardial infarction
-
Loh E, Sutton MS, Wun CC, Rouleau JL, Flaker GC, Gottlieb SS. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997;336: 251-257.
-
(1997)
N Engl J Med
, vol.336
, pp. 251-257
-
-
Loh, E.1
Sutton, M.S.2
Wun, C.C.3
Rouleau, J.L.4
Flaker, G.C.5
Gottlieb, S.S.6
-
92
-
-
84938555022
-
Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: A nationwide cohort study
-
Wolsk E, Lamberts M, Hansen ML, Blanche P, Kober L, Torp-Pedersen C. Thromboembolic risk stratification of patients hospitalized with heart failure in sinus rhythm: A nationwide cohort study. Eur J Heart Fail 2015;17: 828-836.
-
(2015)
Eur J Heart Fail
, vol.17
, pp. 828-836
-
-
Wolsk, E.1
Lamberts, M.2
Hansen, M.L.3
Blanche, P.4
Kober, L.5
Torp-Pedersen, C.6
-
93
-
-
84861037910
-
Warfarin and aspirin in patients with heart failure and sinus rhythm
-
Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, Ammon SE, Graham S, Sacco RL, Mann DL, Mohr JP, Massie BM, Labovitz AJ, Anker SD, Lok DJ, Ponikowski P, Estol CJ, Lip GY, Di Tullio MR, Sanford AR, Mejia V, Gabriel AP, del Valle ML, Buchsbaum R. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med 2012;366: 1859-1869.
-
(2012)
N Engl J Med
, vol.366
, pp. 1859-1869
-
-
Homma, S.1
Thompson, J.L.2
Pullicino, P.M.3
Levin, B.4
Freudenberger, R.S.5
Teerlink, J.R.6
Ammon, S.E.7
Graham, S.8
Sacco, R.L.9
Mann, D.L.10
Mohr, J.P.11
Massie, B.M.12
Labovitz, A.J.13
Anker, S.D.14
Lok, D.J.15
Ponikowski, P.16
Estol, C.J.17
Lip, G.Y.18
Di Tullio, M.R.19
Sanford, A.R.20
Mejia, V.21
Gabriel, A.P.22
Del Valle, M.L.23
Buchsbaum, R.24
more..
-
94
-
-
84871254284
-
Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm
-
Hopper I, Skiba M, Krum H. Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm. Eur J Heart Fail 2013;15: 69-78.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 69-78
-
-
Hopper, I.1
Skiba, M.2
Krum, H.3
-
95
-
-
2942564768
-
The Warfarin/Aspirin Study in Heart failure (WASH): A randomized trial comparing antithrombotic strategies for patients with heart failure
-
Cleland JG, Findlay I, Jafri S, Sutton G, Falk R, Bulpitt C, Prentice C, Ford I, Trainer A, Poole-Wilson PA. The Warfarin/Aspirin Study in Heart failure (WASH): A randomized trial comparing antithrombotic strategies for patients with heart failure. Am Heart J 2004;148: 157-164.
-
(2004)
Am Heart J
, vol.148
, pp. 157-164
-
-
Cleland, J.G.1
Findlay, I.2
Jafri, S.3
Sutton, G.4
Falk, R.5
Bulpitt, C.6
Prentice, C.7
Ford, I.8
Trainer, A.9
Poole-Wilson, P.A.10
-
97
-
-
65249116339
-
Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial
-
Massie BM, Collins JF, Ammon SE, Armstrong PW, Cleland JG, Ezekowitz M, Jafri SM, Krol WF, O'Connor CM, Schulman KA, Teo K,Warren SR. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial. Circulation 2009;119: 1616-1624.
-
(2009)
Circulation
, vol.119
, pp. 1616-1624
-
-
Massie, B.M.1
Collins, J.F.2
Ammon, S.E.3
Armstrong, P.W.4
Cleland, J.G.5
Ezekowitz, M.6
Jafri, S.M.7
Krol, W.F.8
O'Connor, C.M.9
Schulman, K.A.10
Teo, K.11
Warren, S.R.12
-
98
-
-
84892981695
-
Antiplatelet and anticoagulant agents in heart failure: Current status and future perspectives
-
Gurbel PA, Tantry US. Antiplatelet and anticoagulant agents in heart failure: Current status and future perspectives. JACC Heart Fail 2014;2: 1-14.
-
(2014)
JACC Heart Fail
, vol.2
, pp. 1-14
-
-
Gurbel, P.A.1
Tantry, U.S.2
-
99
-
-
84862907587
-
Rivaroxaban in patients with a recent acute coronary syndrome
-
Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 2012;366: 9-19.
-
(2012)
N Engl J Med
, vol.366
, pp. 9-19
-
-
Mega, J.L.1
Braunwald, E.2
Wiviott, S.D.3
Bassand, J.P.4
Bhatt, D.L.5
Bode, C.6
Burton, P.7
Cohen, M.8
Cook-Bruns, N.9
Fox, K.A.10
Goto, S.11
Murphy, S.A.12
Plotnikov, A.N.13
Schneider, D.14
Sun, X.15
Verheugt, F.W.16
Gibson, C.M.17
-
100
-
-
84885025341
-
Clinical outcome endpoints in heart failure trials: A European Society of Cardiology Heart Failure Association consensus document
-
Zannad F, Garcia AA, Anker SD, Armstrong PW, Calvo G, Cleland JG, Cohn JN, Dickstein K, Domanski MJ, Ekman I, Filippatos GS, Gheorghiade M, Hernandez AF, Jaarsma T, Koglin J, Konstam M, Kupfer S, Maggioni AP, Mebazaa A, Metra M, Nowack C, Pieske B, Piña IL, Pocock SJ, Ponikowski P, Rosano G, Ruilope LM, Ruschitzka F, Severin T, Solomon S, Stein K, Stockbridge NL, Stough WG, Swedberg K, Tavazzi L, Voors AA, Wasserman SM, Woehrle H, Zalewski A, McMurray JJ. Clinical outcome endpoints in heart failure trials: A European Society of Cardiology Heart Failure Association consensus document. Eur J Heart Fail 2013;15: 1082-1094.
-
(2013)
Eur J Heart Fail
, vol.15
, pp. 1082-1094
-
-
Zannad, F.1
Garcia, A.A.2
Anker, S.D.3
Armstrong, P.W.4
Calvo, G.5
Cleland, J.G.6
Cohn, J.N.7
Dickstein, K.8
Domanski, M.J.9
Ekman, I.10
Filippatos, G.S.11
Gheorghiade, M.12
Hernandez, A.F.13
Jaarsma, T.14
Koglin, J.15
Konstam, M.16
Kupfer, S.17
Maggioni, A.P.18
Mebazaa, A.19
Metra, M.20
Nowack, C.21
Pieske, B.22
Piña, I.L.23
Pocock, S.J.24
Ponikowski, P.25
Rosano, G.26
Ruilope, L.M.27
Ruschitzka, F.28
Severin, T.29
Solomon, S.30
Stein, K.31
Stockbridge, N.L.32
Stough, W.G.33
Swedberg, K.34
Tavazzi, L.35
Voors, A.A.36
Wasserman, S.M.37
Woehrle, H.38
Zalewski, A.39
McMurray, J.J.40
more..
|